|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.17 USD | -0.33% |
|
-0.62% | -2.93% |
| 01:00pm | BMO Capital Adjusts Price Target on Pfizer to $30 From $34, Maintains Outperform Rating | MT |
| 04:59am | Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug | MT |
Chart calendar Pfizer Inc.
Upcoming events on Pfizer Inc.
| 24/07/2026 | Ex-dividend date - 0.43 USD | 07:00 |
| 04/08/2026 | Earnings presentation | 17:00 |
| 04/08/2026 | Earnings release - Q2 2026 |
Past events on Pfizer Inc.
| 06/06/2026 | Information meeting | 18:00 |
| 05/05/2026 | Earnings presentation | 17:00 |
| 05/05/2026 | Earnings release - Q1 2026 | |
| 23/04/2026 | Annual General Meeting | 16:00 |
| 23/04/2026 | Présentation aux Actionnaires / Analystes | 16:00 |
| 03/02/2026 | Earnings presentation | 18:00 |
| 03/02/2026 | Earnings release - Q4 2025 | 18:00 |
| 10/11/2025 | Information meeting | 16:30 |
| 04/11/2025 | Earnings release - Q3 2025 | |
| 04/11/2025 | Earnings presentation | 18:00 |
| 05/08/2025 | Earnings presentation | 17:00 |
Past dividends on Pfizer Inc.
| 08/05/2026 | Ex-dividend date - 0.43 USD | 07:00 |
| 23/01/2026 | Ex-dividend date - 0.43 USD | 08:00 |
| 07/11/2025 | Ex-dividend date - 0.43 USD | 08:00 |
| 25/07/2025 | Ex-dividend date - 0.43 USD | 07:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 58 496 59 105 -1.03% | 63 627 63 071 0.88% | 62 579 61 941 1.03% | 61 745 | 59 367 | 54 967 |
|
EBITDA Million USD | Released Forecast Spread | 15 590 11 249 38.59% | 28 801 25 482 13.03% | 28 563 25 004 14.23% | 24 750 | 24 039 | 21 132 |
|
EBIT Million USD | Released Forecast Spread | 9 300 8 509 9.3% | 21 788 20 589 5.82% | 21 971 21 223 3.53% | 21 610 | 20 347 | 17 627 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 058 2 301 -54.02% | 8 023 11 544 -30.5% | 7 520 12 438 -39.54% | 11 253 | 12 397 | 11 666 |
|
Net income Million USD | Released Forecast Spread | 2 119 3 040 -30.29% | 8 031 9 732 -17.47% | 7 771 12 287 -36.75% | 10 612 | 10 263 | 9 432 |
|
EPS USD | Released Forecast Spread | 0,37 0,72 -48.44% | 1,41 1,70 -17.17% | 1,36 2,14 -36.34% | 1,97 | 1,90 | 1,61 |
| Announcement Date | 30/01/24 | 04/02/25 | 03/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17 702 14 865 19.08% | 17 763 17 264 2.89% | 13 715 14 051 -2.39% | 14 653 13 531 8.29% | 16 654 16 502 0.92% | 17 557 16 828 4.33% | 14 451 13 802 4.7% | 14 424 | 16 120 | 16 913 | 13 399 | 13 937 | 15 810 | 16 425 |
|
EBITDA Million USD | Released Forecast Spread | 7 478 4 647 60.92% | 6 391 4 136 54.54% | 7 548 6 180 22.14% | 6 940 5 487 26.49% | 7 303 6 229 17.23% | 6 770 6 073 11.47% | 7 172 6 329 13.32% | 5 965 | 7 008 | 6 065 | 5 334 | |||
|
EBIT Million USD | Released Forecast Spread | 7 035 3 978 76.86% | 4 672 3 357 39.18% | 5 930 4 982 19.02% | 5 315 4 410 20.51% | 5 641 4 704 19.93% | 5 083 4 275 18.89% | 5 559 5 329 4.31% | 4 999 | 6 021 | 5 094 | 4 809 | 5 060 | 6 154 | 4 685 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 715 2 616 80.24% | -10,0 2 104 -100.48% | 2 785 3 880 -28.22% | 3 044 2 468 23.34% | 3 334 3 240 2.9% | -1 642 3 002 -154.71% | 3 170 3 966 -20.07% | 3 092 | 4 645 | 2 544 | ||||
|
Net income Million USD | Released Forecast Spread | 4 465 1 725 158.79% | 410 1 002 -59.1% | 2 967 2 913 1.86% | 2 910 2 063 41.07% | 3 541 2 334 51.72% | -1 648 2 208 -174.64% | 2 687 2 981 -9.86% | 2 512 | 3 389 | 2 253 | 2 777 | 3 168 | 4 110 | 2 878 |
|
EPS USD | Released Forecast Spread | 0,78 0,30 160.81% | 0,07 0,20 -65.43% | 0,52 0,51 2.91% | 0,51 0,36 41.65% | 0,62 0,44 42.49% | -0,29 0,39 -173.87% | 0,47 0,52 -9.48% | 0,44 | 0,59 | 0,39 | 0,49 | 0,56 | 0,72 | 0,50 |
| Announcement Date | 29/10/24 | 04/02/25 | 29/04/25 | 05/08/25 | 04/11/25 | 03/02/26 | 05/05/26 | - | - | - | - | - | - | - |
| 14/07/2026 | Ex-dividend date - 0.052 CNY | 07:00 | |
| 15/07/2026 | Earnings release - Q2 2026 | 13:45 | |
| 15/07/2026 | Earnings presentation | 15:30 | |
| 15/07/2026 | Ex-dividend date - 1.73 USD | 07:00 | |
| 15/07/2026 | Earnings release - Q2 2026 | ||
| 15/07/2026 | Earnings presentation | 15:00 | |
| 15/07/2026 | Extraordinary General Meeting | 09:30 | |
| 15/07/2026 | Ex-dividend date - 0.05 CNY | 07:00 | |
| 15/07/2026 | Ex-dividend date - 0.2 CNY | 07:00 | |
| 15/07/2026 | Ex-dividend date - 0.057 CNY | 07:00 |
Past sector events for Pfizer Inc.
| Today | Ex-dividend date - 0.77711 EUR | 07:00 | |
| 11/07/2026 | Board of Directors Meeting | 10:00 | |
| 10/07/2026 | Ex-dividend date - 8 INR | 07:00 | |
| 10/07/2026 | Extraordinary General Meeting | 09:00 | |
| 10/07/2026 | Extraordinary General Meeting | 09:00 | |
| 10/07/2026 | Ex-dividend date - 0.17248 HKD | 07:00 | |
| 10/07/2026 | Annual General Meeting | 08:30 | |
| 10/07/2026 | Présentation aux Actionnaires / Analystes | 08:30 | |
| 10/07/2026 | Board of Directors Meeting | ||
| 09/07/2026 | Information meeting | 14:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
- Calendar Pfizer Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















